Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 90

    1.

    Genomic studies of mood disorders -- the brain as a muscle?

    Niculescu AB.

    Genome Biol. 2005;6(4):215. Epub 2005 Mar 24. Review.

    PMID:
    15833130
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Microarray analysis of cultured human brain aggregates following cortisol exposure: implications for cellular functions relevant to mood disorders.

    Salaria S, Chana G, Caldara F, Feltrin E, Altieri M, Faggioni F, Domenici E, Merlo-Pich E, Everall IP.

    Neurobiol Dis. 2006 Sep;23(3):630-6. Epub 2006 Jul 17.

    PMID:
    16844382
    [PubMed - indexed for MEDLINE]
    3.

    The fibroblast growth factor system and mood disorders.

    Turner CA, Akil H, Watson SJ, Evans SJ.

    Biol Psychiatry. 2006 Jun 15;59(12):1128-35. Epub 2006 May 2. Review.

    PMID:
    16631131
    [PubMed - indexed for MEDLINE]
    4.

    The genomics of mood disorders.

    Alesci S, Rodak M, Ilias I, Zhou R, Manji HK.

    Prog Brain Res. 2006;158:129-39. Review. No abstract available.

    PMID:
    17027694
    [PubMed - indexed for MEDLINE]
    5.

    Volume deficits of subcortical nuclei in mood disorders A postmortem study.

    Bielau H, Trübner K, Krell D, Agelink MW, Bernstein HG, Stauch R, Mawrin C, Danos P, Gerhard L, Bogerts B, Baumann B.

    Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):401-12. Epub 2005 Aug 17.

    PMID:
    16080015
    [PubMed - indexed for MEDLINE]
    6.

    An update on regional brain volume differences associated with mood disorders.

    Campbell S, MacQueen G.

    Curr Opin Psychiatry. 2006 Jan;19(1):25-33. Review.

    PMID:
    16612175
    [PubMed - indexed for MEDLINE]
    7.

    Mood patterns and classification in bipolar disorder.

    Benazzi F.

    Curr Opin Psychiatry. 2006 Jan;19(1):1-8. Review.

    PMID:
    16612171
    [PubMed - indexed for MEDLINE]
    8.

    Serotonin transporter gene influences the time course of improvement of "core" depressive and somatic anxiety symptoms during treatment with SSRIs for recurrent mood disorders.

    Serretti A, Mandelli L, Lorenzi C, Pirovano A, Olgiati P, Colombo C, Smeraldi E.

    Psychiatry Res. 2007 Jan 15;149(1-3):185-93. Epub 2006 Dec 8.

    PMID:
    17157919
    [PubMed - indexed for MEDLINE]
    9.

    Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway.

    Gould TD, Dow ER, O'Donnell KC, Chen G, Manji HK.

    CNS Neurol Disord Drug Targets. 2007 Jun;6(3):193-204. Review.

    PMID:
    17511616
    [PubMed - indexed for MEDLINE]
    10.

    Reduced expression of glyoxalase-1 mRNA in mood disorder patients.

    Fujimoto M, Uchida S, Watanuki T, Wakabayashi Y, Otsuki K, Matsubara T, Suetsugi M, Funato H, Watanabe Y.

    Neurosci Lett. 2008 Jun 20;438(2):196-9. Epub 2008 Apr 12.

    PMID:
    18455873
    [PubMed - indexed for MEDLINE]
    11.

    Increased levels of glutamate in brains from patients with mood disorders.

    Hashimoto K, Sawa A, Iyo M.

    Biol Psychiatry. 2007 Dec 1;62(11):1310-6. Epub 2007 Jun 15.

    PMID:
    17574216
    [PubMed - indexed for MEDLINE]
    12.

    Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.

    Ogren SO, Kuteeva E, Hökfelt T, Kehr J.

    CNS Drugs. 2006;20(8):633-54. Review.

    PMID:
    16863269
    [PubMed - indexed for MEDLINE]
    13.

    Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets.

    Carlson PJ, Singh JB, Zarate CA Jr, Drevets WC, Manji HK.

    NeuroRx. 2006 Jan;3(1):22-41. Review.

    PMID:
    16490411
    [PubMed - indexed for MEDLINE]
    14.

    Reductions in cholesterol and synaptic markers in association cortex in mood disorders.

    Beasley CL, Honer WG, Bergmann K, Falkai P, Lütjohann D, Bayer TA.

    Bipolar Disord. 2005 Oct;7(5):449-55.

    PMID:
    16176438
    [PubMed - indexed for MEDLINE]
    15.

    [Neurotrophic factors and their role in the pathogenesis of affective disorders].

    Filuś JF, Rybakowski J.

    Psychiatr Pol. 2005 Sep-Oct;39(5):883-97. Review. Polish.

    PMID:
    16358589
    [PubMed - indexed for MEDLINE]
    16.

    Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder.

    Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA.

    Bipolar Disord. 2008 Feb;10(1):1-37. Review.

    PMID:
    18199239
    [PubMed - indexed for MEDLINE]
    17.

    The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology.

    Martin EI, Ressler KJ, Binder E, Nemeroff CB.

    Psychiatr Clin North Am. 2009 Sep;32(3):549-75. Review.

    PMID:
    19716990
    [PubMed - indexed for MEDLINE]
    18.

    BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia.

    Rybakowski JK.

    Pharmacogenomics. 2008 Nov;9(11):1589-93. Review.

    PMID:
    19018714
    [PubMed - indexed for MEDLINE]
    19.

    Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population.

    Kishi T, Kitajima T, Tsunoka T, Okumura T, Ikeda M, Okochi T, Kinoshita Y, Kawashima K, Yamanouchi Y, Ozaki N, Iwata N.

    Neuromolecular Med. 2009;11(2):114-22. Epub 2009 Jun 20.

    PMID:
    19544013
    [PubMed - indexed for MEDLINE]
    20.

    Classifying mood disorders by age-at-onset instead of polarity.

    Benazzi F.

    Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):86-93. Epub 2008 Oct 27.

    PMID:
    18992784
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk